Cargando…
Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer
SIMPLE SUMMARY: Stromal tumor infiltrating lymphocytes (sTIL) are a validated predictive and prognostic biomarker in non-luminal breast cancer. Our aim was to evaluate their clinical relevance in luminal (hormone receptor positive, HER2 negative) early breast cancer. Our results show that, although...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216816/ https://www.ncbi.nlm.nih.gov/pubmed/37345183 http://dx.doi.org/10.3390/cancers15102846 |
_version_ | 1785048388391141376 |
---|---|
author | García-Torralba, Esmeralda Pérez Ramos, Miguel Ivars Rubio, Alejandra Navarro-Manzano, Esther Blaya Boluda, Noel de la Morena Barrio, Pilar García-Garre, Elisa Martínez Díaz, Francisco Chaves-Benito, Asunción García-Martínez, Elena Ayala de la Peña, Francisco |
author_facet | García-Torralba, Esmeralda Pérez Ramos, Miguel Ivars Rubio, Alejandra Navarro-Manzano, Esther Blaya Boluda, Noel de la Morena Barrio, Pilar García-Garre, Elisa Martínez Díaz, Francisco Chaves-Benito, Asunción García-Martínez, Elena Ayala de la Peña, Francisco |
author_sort | García-Torralba, Esmeralda |
collection | PubMed |
description | SIMPLE SUMMARY: Stromal tumor infiltrating lymphocytes (sTIL) are a validated predictive and prognostic biomarker in non-luminal breast cancer. Our aim was to evaluate their clinical relevance in luminal (hormone receptor positive, HER2 negative) early breast cancer. Our results show that, although sTIL are associated with a better response to neoadjuvant chemotherapy, they are also associated with worse biological features (proliferation, higher stage) and poorer prognosis in luminal B breast cancer. TIL might improve prognostic stratification and contribute to therapeutic decision-making in the early high-risk setting of luminal B breast cancer. ABSTRACT: Luminal breast cancer (BC) is associated with less immune activation, and the significance of stromal lymphocytic infiltration (sTIL) is more uncertain than in other BC subtypes. The aim of this study was to investigate the predictive and prognostic value of sTIL in early luminal BC. The study was performed with an observational design in a prospective cohort of 345 patients with predominantly high-risk luminal (hormone receptor positive, HER2 negative) BC and with luminal B features (n = 286), in which the presence of sTIL was analyzed with validated methods. Median sTIL infiltration was 5% (Q1–Q3 range (IQR), 0–10). We found that sTIL were associated with characteristics of higher biological and clinical aggressiveness (tumor and lymph node proliferation and stage, among others) and that the percentage of sTIL was predictive of pathologic complete response in patients treated with neoadjuvant chemotherapy (OR: 1.05, 95%CI 1.02–1.09, p < 0.001). The inclusion of sTIL (any level of lymphocytic infiltration: sTIL > 0%) in Cox regression multivariable prognostic models was associated with a shorter relapse-free interval (HR: 4.85, 95%CI 1.33–17.65, p = 0.016) and significantly improved its performance. The prognostic impact of sTIL was independent of other clinical and pathological variables and was mainly driven by its relevance in luminal B BC. |
format | Online Article Text |
id | pubmed-10216816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102168162023-05-27 Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer García-Torralba, Esmeralda Pérez Ramos, Miguel Ivars Rubio, Alejandra Navarro-Manzano, Esther Blaya Boluda, Noel de la Morena Barrio, Pilar García-Garre, Elisa Martínez Díaz, Francisco Chaves-Benito, Asunción García-Martínez, Elena Ayala de la Peña, Francisco Cancers (Basel) Article SIMPLE SUMMARY: Stromal tumor infiltrating lymphocytes (sTIL) are a validated predictive and prognostic biomarker in non-luminal breast cancer. Our aim was to evaluate their clinical relevance in luminal (hormone receptor positive, HER2 negative) early breast cancer. Our results show that, although sTIL are associated with a better response to neoadjuvant chemotherapy, they are also associated with worse biological features (proliferation, higher stage) and poorer prognosis in luminal B breast cancer. TIL might improve prognostic stratification and contribute to therapeutic decision-making in the early high-risk setting of luminal B breast cancer. ABSTRACT: Luminal breast cancer (BC) is associated with less immune activation, and the significance of stromal lymphocytic infiltration (sTIL) is more uncertain than in other BC subtypes. The aim of this study was to investigate the predictive and prognostic value of sTIL in early luminal BC. The study was performed with an observational design in a prospective cohort of 345 patients with predominantly high-risk luminal (hormone receptor positive, HER2 negative) BC and with luminal B features (n = 286), in which the presence of sTIL was analyzed with validated methods. Median sTIL infiltration was 5% (Q1–Q3 range (IQR), 0–10). We found that sTIL were associated with characteristics of higher biological and clinical aggressiveness (tumor and lymph node proliferation and stage, among others) and that the percentage of sTIL was predictive of pathologic complete response in patients treated with neoadjuvant chemotherapy (OR: 1.05, 95%CI 1.02–1.09, p < 0.001). The inclusion of sTIL (any level of lymphocytic infiltration: sTIL > 0%) in Cox regression multivariable prognostic models was associated with a shorter relapse-free interval (HR: 4.85, 95%CI 1.33–17.65, p = 0.016) and significantly improved its performance. The prognostic impact of sTIL was independent of other clinical and pathological variables and was mainly driven by its relevance in luminal B BC. MDPI 2023-05-20 /pmc/articles/PMC10216816/ /pubmed/37345183 http://dx.doi.org/10.3390/cancers15102846 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article García-Torralba, Esmeralda Pérez Ramos, Miguel Ivars Rubio, Alejandra Navarro-Manzano, Esther Blaya Boluda, Noel de la Morena Barrio, Pilar García-Garre, Elisa Martínez Díaz, Francisco Chaves-Benito, Asunción García-Martínez, Elena Ayala de la Peña, Francisco Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer |
title | Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer |
title_full | Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer |
title_fullStr | Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer |
title_full_unstemmed | Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer |
title_short | Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer |
title_sort | clinical meaning of stromal tumor infiltrating lymphocytes (stil) in early luminal b breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216816/ https://www.ncbi.nlm.nih.gov/pubmed/37345183 http://dx.doi.org/10.3390/cancers15102846 |
work_keys_str_mv | AT garciatorralbaesmeralda clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT perezramosmiguel clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT ivarsrubioalejandra clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT navarromanzanoesther clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT blayaboludanoel clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT delamorenabarriopilar clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT garciagarreelisa clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT martinezdiazfrancisco clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT chavesbenitoasuncion clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT garciamartinezelena clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer AT ayaladelapenafrancisco clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer |